56 research outputs found
A brain-computer interface for potential non-verbal facial communication based on EEG signals related to specific emotions
Unlike assistive technology for verbal communication, the braināmachine or brainācomputer interface (BMI/BCI) has not been established as a nonverbal communication tool for amyotrophic lateral sclerosis (ALS) patients. Face-to-face communication enables access to rich emotional information, but individuals suffering from neurological disorders, such as ALS and autism, may not express their emotions or communicate their negative feelings. Although emotions may be inferred by looking at facial expressions, emotional prediction for neutral faces necessitates advanced judgment. The process that underlies brain neuronal responses to neutral faces and causes emotional changes remains unknown. To address this problem, therefore, this study attempted to decode conditioned emotional reactions to neutral face stimuli. This direction was motivated by the assumption that if electroencephalogram (EEG) signals can be used to detect patientsā emotional responses to specific inexpressive faces, the results could be incorporated into the design and development of BMI/BCI-based nonverbal communication tools. To these ends, this study investigated how a neutral face associated with a negative emotion modulates rapid central responses in face processing and then identified cortical activities. The conditioned neutral face-triggered event-related potentials that originated from the posterior temporal lobe statistically significantly changed during late face processing (600ā700 ms) after stimulus, rather than in early face processing activities, such as P1 and N170 responses. Source localization revealed that the conditioned neutral faces increased activity in the right fusiform gyrus. This study also developed an efficient method for detecting implicit negative emotional responses to specific faces by using EEG signals
Roles of Arterial Baroreceptor Reflex During Bezold-Jarisch Reflex
Among the many cardiopulmonary reflexes, this review specifically examines the roles of the arterial baroreflex during the Bezold-Jarisch reflex (BJR). Activation of cardiopulmonary vagal afferent C-fibers induces hypotension, bradycardia, and apnea, which are known collectively as the BJR; myocardial ischemia and infarction might induce the BJR. Arterial baroreflex has been established as an important negative feedback system that stabilizes arterial blood pressure against exogenous pressure perturbations. Therefore, understanding the functions of the arterial baroreflex during the BJR is crucial for elucidating its pathophysiological implications. The main central pathways of the BJR and the baroreflex are outlined herein, particularly addressing the common pathway between the reflexes. Furthermore, the pathophysiological roles of the arterial baroreflex during the BJR are described along with a brief discussion of pathophysiological merits and shortcomings of the reflexes
Thrombolysis with Low-Dose Tissue Plasminogen Activator 3ā4.5Ā h After Acute Ischemic Stroke in Five Hospital Groups in Japan
Clinical data from Japan on the safety and real-world outcomes of alteplase (tPA) thrombolysis in the extended therapeutic window are lacking. The aim of this study was to assess the safety and real-world outcomes of tPA administered within 3-4.5 h of stroke onset. The study comprised consecutive acute ischemic stroke patients (n = 177) admitted across five hospitals between September 2012 and August 2014. Patients received intravenous tPA within <3 or 3-4.5 h of stroke onset. Endovascular therapy was used for tPA-refractory patients. In the 3-4.5 h subgroup (31.6 % of patients), tPA was started 85 min later than the <3 h group (220 vs. 135 min, respectively). However, outcome measures were not significantly different between the <3 and 3-4.5 h subgroups for recanalization rate (67.8 vs. 57.1 %), symptomatic intracerebral hemorrhage (2.5 vs. 3.6 %), modified Rankin Scale score of 0-1 at 3 months (36.0 vs. 23.4 %), and mortality (6.9 vs. 8.3 %). We present data from 2005 to 2012 using a therapeutic window <3 h showing comparable results. tPA following endovascular therapy with recanalization might be superior to tPA only with recanalization (81.0 vs. 59.1 %). Compared with administration within 3 h of ischemic stroke onset, tPA administration within 3-4.5 h of ischemic stroke onset in real-world stroke emergency settings at multiple sites in Japan is as safe and has the same outcomes
Three dimensional motion analyses for rehabilitation version of Awa Odori exercise and the expectancy of physical effects
āAwa Odori Exercise -Rehabilitation version- was developed in 2006 for the new
trial of physical exercise for the aging and the impaired person with lower balance performance
in Tokushima prefecture, Japan. Public relations of this exercise had been
spreading over Tokushima since then. The characteristics of the exercise were highly
familiar with most of people in Tokushima because of popularity in original āAwa Odoriā.
This study proposed the efficacies of Awa Odori Exercise as a rehabilitation exercise. This
exercise expected the flexible balance reinforcements and the substitution for walking
training with prevention of fall, bedridden and participating restriction for the old people,
also promoting the health in Tokushima
Gait and posture assessments of a patient treated with deep brain stimulation in dystonia using three-dimensional motion analysis systems
Kinesiologic analysis of gait disorders, postural instabilities and abnormal movements
is quite difficult to assess objectively by clinical observation, such as by specific
scale and video recordings. In this study, we reported one of the aspects of the usefulness
of three-dimensional motion analysis (Vicon Systems, Oxford, United Kingdom), which
can measure inclusive data of movement disorders and substitute for conventional assessments.
A 49-year-old man who had various dystonic symptoms, mainly on his left side
of the body, responded well to deep brain stimulation (DBS). The examination quantified
how the involuntary movements or other symptoms with dystonia changed before and
after treatments
Secondary school curriculum in science for scientific literacy : Results and problems to be solved)
Relationship between Barthel Index scores during the acute phase of rehabilitation and subsequent ADL in stroke patients
The Barthel Index (BI) cannot be used to measure initial stroke severity or by extension, to stratify patients by severity in acute stroke trials because most patients are bedbound in the first few hours after stroke, either by their deficit or by medical directive. Our objectives were to clarify the threshold of acute BI for use in the prediction of subsequent independence in activities of daily living (ADL) and to assist in the definition of acute stroke rehabilitation goals. Subjects comprised 78 patients out of 191 inpatients admitted with acute stroke at our hospital during 2006-2007. The BI ADL score was divided into 2 ranges (BIā§60 andā¦40), in a process similar to previous studies. During the acute period (from onset to approximately 3 weeks), all patients with a BIā§40 could improve their ADL in 6 months. Patients with a BIā¦40 exhibited two ADL recovery outcomes (improved and no change) at 6 months. We also found that the skill level of basic activities related to standing was significant indicator of BI improvement (P<0.001). BI scores determined at approximately 3 weeks were reliable predictors of ADL disabilities at 6 months
Sitagliptin and Carotid Atherosclerosis in Type 2 Diabetes
Background
Experimental studies have suggested that dipeptidyl peptidase-4 (DPP-4) inhibitors provide cardiovascular protective effects. We performed a randomized study to evaluate the effects of sitagliptin added on to the conventional therapy compared with conventional therapy alone (diet, exercise, and/or drugs, except for incretin-related agents) on the intima-media thickness (IMT) of the carotid artery, a surrogate marker for the evaluation of atherosclerotic cardiovascular disease, in people with type 2 diabetes mellitus (T2DM).
Methods and Findings
We used a multicenter PROBE (prospective, randomized, open label, blinded endpoint) design. Individuals aged ā„30 y with T2DM (6.2% ā¤ HbA1c < 9.4%) were randomly allocated to receive either sitagliptin (25 to 100 mg/d) or conventional therapy. Carotid ultrasound was performed at participating medical centers, and all parameters were measured in a core laboratory. Of the 463 enrolled participants with T2DM, 442 were included in the primary analysis (sitagliptin group, 222; conventional therapy group, 220). Estimated mean (Ā± standard error) common carotid artery IMT at 24 mo of follow-up in the sitagliptin and conventional therapy groups was 0.827 Ā± 0.007 mm and 0.837 Ā± 0.007 mm, respectively, with a mean difference of ā0.009 mm (97.2% CI ā0.028 to 0.011, p = 0.309). HbA1c level at 24 mo was significantly lower with sitagliptin than with conventional therapy (6.56% Ā± 0.05% versus 6.72%Ā± 0.05%, p = 0.008; group mean difference ā0.159, 95% CI ā0.278 to ā0.041). Episodes of serious hypoglycemia were recorded only in the conventional therapy group, and the rate of other adverse events was not different between the two groups. As it was not a placebo-controlled trial and carotid IMT was measured as a surrogate marker of atherosclerosis, there were some limitations of interpretation.
Conclusions
In the PROLOGUE study, there was no evidence that treatment with sitagliptin had an additional effect on the progression of carotid IMT in participants with T2DM beyond that
achieved with conventional treatment
Automatic Regulation of Hemodynamic Variables in Acute Heart Failure by a Multiple Adaptive Predictive Controller Based on Neural Networks
The Japanese Clinical Practice Guideline for acute kidney injury 2016
Acute kidney injury (AKI) is a syndrome which has a broad range of etiologic factors depending on different clinical settings. Because AKI has significant impacts on prognosis in any clinical settings, early detection and intervention are necessary to improve the outcomes of AKI patients. This clinical guideline for AKI was developed by a multidisciplinary approach with nephrology, intensive care medicine, blood purification, and pediatrics. Of note, clinical practice for AKI management which was widely performed in Japan was also evaluated with comprehensive literature search
- ā¦